CClinicalTrials.gg
CompletedNCT01914848MAPSUpdated Jun 6, 2016

Multiprofessional Advance Care Planning and Shared Decision Making for End of Life Care

An interventional study of Advance Care Planning ACP and Control Group in Palliative Patients and Surrogate Decision Maker, sponsored by University of Zurich. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-06-06.

Sponsored by University of Zurich · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
115
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Multiprofessional Advance Care Planning and shared decision making for end of live care for terminal patients and their relatives.

The aim of this study is to develop, implement and test a complex intervention for improving patients' preparation for and participation in end of life decisions. In cooperation with local, national and international partners, the investigators will focus on strategies to enhance advance care planning and shared decision making on end of life issues, and documentation and transferability of end of life decisions across health care settings in coordinated approach involving patients, their families and care givers (in and out of hospital).

02

Conditions studied

  • Palliative Patients
  • Surrogate Decision Maker

Browse trials for

03

In context

Death

572 studies on the registry are indexed under Death; 111 are open to participants now.

This study's enrollment of 115 is below the median of 133 across 260 interventional studies indexed under Death.

Browse Death studies →

Lead sponsor

University of Zurich is the lead sponsor of 1,030 studies on the registry; 130 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion criteria: -patients in which the treating physician on the ward would not be surprised if the patient died during the next year (surprise question of Weissman et al 2011)

  • male and female patients above 18 years of age
  • signed informed consent after being informed
  • patients able to appoint a surrogate decision maker (SM) and/or responsible physician to be contacted after discharge

Exclusion criteria: -patients not capable of speaking german

  • patients having no responsible physician to be contacted after discharge and no relative/future surrogate decision maker (SM)
  • inhouse patients being discharged within the next 2 days or ambulatory patients not regularly coming to the wards (at least every two month)
  • patients assessed by their physician to be in obvious denial of their situation (illness/prognosis)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
115 participants (actual)

Study arms

  • Active comparator
    Control Group

    A routine care discharge planning with the social service

    Other: Control Group

  • Experimental
    Advance Care Planning ACP

    Patient get a decision aid video and library and up to 3 consultations with qualified Advance Care Planning Facilitators. --------------------------------------------------------------------------------

    Other: Advance Care Planning ACP

Interventions

  • OtherAdvance Care Planning ACP

    Patient of the intervention group get a decision aid video and library and up to 3 consultations with qualified Advance Care Planning Facilitators.

  • OtherControl Group

    A routine care discharge planning with the social service

06

What researchers measure

Primary outcomes

  1. end of life wish on resuscitation known (if alive) or fulfilled(if dead) after 6 month by responsible physician and/or surrogate decision maker (SM)

    Time frame: during 2 weeks six months after discharge

Secondary outcomes

  1. end of live decisions on last place of care, antibiotics for pneumonia, feeding tube, intravenous fluids, dialysis, intubation and sedation,

    Time frame: during 2 weeks six months after discharge

  2. decisional conflict scale ("DCS"), O Connor et al 1995

    Time frame: at discharge and during 2 Weeks six months after discharge

  3. Satisfaction with information and care, (see Detering et al 2010)

    Time frame: at discharge

  4. Hospital Anxiety and Depression scale ("HADS")

    Time frame: discharge and during 2 weeks six months after discharge

  5. Having an Advance directive

    Time frame: at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge

  6. Having an appointed surrogate decision maker

    Time frame: at discharge, during 2 weeks three month after discharge and during 2 weeks six month after discharge

  7. Any hospital stay

    Time frame: during 2 weeks three months after discharge and during 2 weeks six months after discharge

  8. Decisions regarding end of life issues already having been made/taken place

    Time frame: during 2 weeks six months after discharge

  9. open question on important medical decisions being made

    Time frame: during 2 weeks three months after discharge

  10. Treatment against patients wishes

    Time frame: during 2 weeks three months after discharge and during 2 weeks six months after discharge, or 3 month after death

  11. Distress of Patients or relatives because of content of the consultation

    Time frame: at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge

07

Study locations

1 site
  • University Hospital Zurich, Clinical Ethics
    Zurich, ZH 8091, Switzerland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 6, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01914848
Lead sponsor
University of Zurich
Responsible party
Sponsor
First posted
Aug 2, 2013
Start date
Jul 2013
Primary completion
Apr 2015
Completion
Aug 2015
Last update
Jun 6, 2016

Study contacts

Tanja Krones, MD
principal investigator · University Hospital Zurich, Clinical Ethics

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion